Rebrain services provide precise brain targeting for DBS neurosurgery, enhancing patient outcomes in Parkinson’s disease and Essential Tremor treatments

RebrAIn’s news

“La Gazette du Laboratoire” Features RebrAIn’s Breakthrough in Deep Brain Stimulation

We are pleased to announce that La Gazette du Laboratoire has featured RebrAIn for our revolutionary advancements in neurosurgical targeting for Deep Brain Stimulation (DBS).

The article highlights our collaboration with SATT Aquitaine Science Transfert and the development of our supervised AI-driven platform, OptimDBS, designed to enhance the precision and effectiveness of DBS treatments.

Learn more about how RebrAIn is transforming neurosurgery and improving patient outcomes by reading the full article here, in french.

An English translation by Google is available here.

Our latest public updates

From Patient to Practice: RebrAIn Wins the Resah Tender

From Patient to Practice: RebrAIn Wins the Resah Tender

The Strategic Importance of This Tender This success marks a major strategic turning point for RebrAIn, as the Resah procurement center plays a key role in the public healthcare sector in France. By enabling the member hospitals to choose the most effective...